Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes PROG NEUROBIOL
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol BLOOD ADV
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients ANN HEMATOL
Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicity NAT COMMUN
Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLC MOL ONCOL
A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection BONE MARROW TRANSPL
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study LANCET HAEMATOL
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study BLOOD ADV
Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation BONE MARROW TRANSPL
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study BRIT J HAEMATOL